Connective tissue disease in patients presenting with Raynaud's phenomenon alone.

Por Kallenberg, C G
Publicado em 1991

What is new in systemic vasculitis?

Por KALLENBERG, C, TERVAERT, J
Publicado em 2000

The antiphospholipid syndrome II

Por Bijl, M, Kallenberg, C
Publicado em 2004

A 10% ready-to-use intravenous human immunoglobulin offers potential economic advantages over a lyophilized product in the treatment of primary immunodeficiency

Por Kallenberg, C G M
Publicado em 2007

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: where to go?

Por Kallenberg, C G M
Publicado em 2011

Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?

Por Roozendaal, C, Kallenberg, C G M
Publicado em 1999

Treatment of severe thrombocytopenia in systemic lupus erythematosus with intravenous gammaglobulin.

Por ter Borg, E J, Kallenberg, C G
Publicado em 1992

The cellular immune response to cell-associated and cell-free cytomegalovirus (CMV) antigens after primary CMV-infection in non-immunocompromised hosts: development and maintenance...

Por Roenhorst, H W, Kallenberg, C G, The, T H
Publicado em 1988

Monocyte activation in patients with Wegener's granulomatosis

Por Kobold, A., Kallenberg, C., Tervaert, J. W.
Publicado em 1999

Fatigue and immune activity in Sjögren's syndrome

Por Bax, H, Vriesendorp, T, Kallenberg, C, Kalk, W
Publicado em 2002

Suppression of DNA synthesis by con A-activated human lymphocytes: role of monocytes in con A-induced suppression.

Por Kallenberg, C G, de Gast, G C, The, T H
Publicado em 1980

Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus

Por Bijl, M, Horst, G, Limburg, P, Kallenberg, C
Publicado em 2001

Suppression of DNA synthesis by Con A-activated human lymphocytes: Stimulation by con A bound to non-T cells unless removed after activation.

Por De Gast, G C, The, T H, Ponds, E, Kallenberg, C
Publicado em 1977

Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA.

Por Mulder, A H, Stegeman, C A, Kallenberg, C G
Publicado em 1995

Decreased nailfold capillary density in Raynaud's phenomenon: a reflection of immunologically mediated local and systemic vascular disease?

Por Houtman, P M, Kallenberg, C G, Wouda, A A, The, T H
Publicado em 1985

Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.

Por Kallenberg, C G, Pastoor, G W, Wouda, A A, The, T H
Publicado em 1982

Patients with systemic lupus erythematosus and Jaccoud's arthropathy: a clinical subset with an increased C reactive protein response?

Por Spronk, P E, ter Borg, E J, Kallenberg, C G
Publicado em 1992

Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk

Por Bijl, M, Horst, G, Bootsma, H, Limburg, P, Kallenberg, C
Publicado em 2003

Transient arthritis with positive tests for rheumatoid factor as presenting sign of shunt nephritis.

Por ter Borg, E J, Van Rijswijk, M H, Kallenberg, C G
Publicado em 1991

Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE)

Por Bijl, M, Horst, G, Limburg, P C, Kallenberg, C G M
Publicado em 2001